These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3006675)

  • 21. [(NA++K+)-ATPase inhibitor from bovine hypothalamus].
    Fu Y
    Zhonghua Yi Xue Za Zhi; 1990 Aug; 70(8):442-5, 32. PubMed ID: 2174283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
    Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril inhibits ouabain-sensitive Na+/K+-ATPase.
    Accetto R; Rinaldi G; Weder AB
    Clin Physiol Biochem; 1989; 7(2):101-8. PubMed ID: 2547542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous digitalis-like activity in mammalian brain.
    Fishman MC
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4661-3. PubMed ID: 228305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
    Lichtstein D; Samuelov S; Gati I; Felix AM; Gabriel TF; Deutsch J
    J Endocrinol; 1991 Jan; 128(1):71-8. PubMed ID: 1847965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
    Tamura M; Konishi F; Inagami T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K; Hara N; Tsukada Y
    J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
    Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
    J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes.
    Aunis D; García AG
    Br J Pharmacol; 1981 Jan; 72(1):31-40. PubMed ID: 6164427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca-dependent inhibitor of the Na+K ATPase extracted from human red cell membranes: distinction and independence from calmodulin.
    Yingst DR; Polasek DM; Marcovitz MJ
    Prog Clin Biol Res; 1984; 168():127-32. PubMed ID: 6151187
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucocorticoid-induced alterations in the sodium potassium pump of the human erythrocyte.
    Kaji DM; Thakkar U; Kahn T
    J Clin Invest; 1981 Aug; 68(2):422-30. PubMed ID: 6267104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digitalis-like properties of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA
    J Neurol Sci; 1989 Apr; 90(2):217-30. PubMed ID: 2542468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of synaptosomal membrane Na+, K(+)-ATPase inhibitors.
    Rodríguez de Lores Arnaiz G; Peña C
    Neurochem Int; 1995; 27(4-5):319-27. PubMed ID: 8845732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.
    Illescas M; Ricote M; Mendez E; G-Robles R; Sancho J
    FEBS Lett; 1990 Feb; 261(2):436-40. PubMed ID: 2155831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of human urine-derived digitalis-like factor.
    Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
    Biochem Biophys Res Commun; 1988 Aug; 154(3):847-53. PubMed ID: 2841934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bufodienolides as endogenous Na+, K+-ATPase inhibitors: biosynthesis in bovine and rat adrenals.
    Lichtstein D; Steinitz M; Gati I; Samuelov S; Deutsch J; Orly J
    Clin Exp Hypertens; 1998; 20(5-6):573-9. PubMed ID: 9682913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of cardiac glycoside inhibition of (Na+ + K+)-ATPase by membrane lipids. Difference between species.
    Abeywardena MY; Charnock JS
    Biochim Biophys Acta; 1983 Mar; 729(1):75-84. PubMed ID: 6299349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA; Riordan JF; Tosteson DC
    J Biol Chem; 1988 Jan; 263(2):646-51. PubMed ID: 2826458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure.
    Schneider R; Antolovic R; Kost H; Sich B; Kirch U; Tepel M; Zidek W; Schoner W
    Clin Exp Hypertens; 1998; 20(5-6):593-9. PubMed ID: 9682915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.